The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...

Second Ashland weight loss clinic accused of administering non-FDA approved drugs. Mary Jane Epling, The Daily Independent, Ashland, Ky. Sun, May 25, 2025 at 3:59 AM UTC. 4 min read.

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...

Please provide your email address to receive an email when new articles are posted on . Large-data AI models may also be used to identify non-FDA-approved drugs for Parkinson’s disease. There is ...

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug. Jan. 31, 2025 ... Despite excellent execution of its clinical strategy over the past several months and two new drugs approved, ...

First FDA-approved non-addictive painkiller has Yale roots. Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s. ... Dib-Hajj explains ...

The drugs have been in short supply since 2022, soon after the FDA approved Wegovy for weight loss purposes. Novo Nordisk said it made a $6.5 billion investment to increase production in the U.S.

Key Takeaways. U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults ...